OBJECTIVE: Women with diabetes (DM), both pre-gestational and gestational (GDM), have been excluded from previous antenatal corticosteroid (ACS) trials; thus, the effect of ACS on neonatal outcomes in this population is unknown. Our objective was to estimate whether ACS has differential effectiveness among women with and without DM with regard to preterm neonatal morbidity. STUDY DESIGN: A secondary analysis of an observational cohort of 115,502 women and their neonates born in 25 U.S. hospitals (2008)(2009)(2010)(2011). Women who delivered at 23 0/7-33 6/7 weeks' gestation and received ACS (categorized as partial, 1 course, or > 1 course) were compared to those who did not receive ACS. Women with antepartum stillbirth and women who delivered a neonate that was not resuscitated were excluded. The primary outcome was neonatal respiratory distress syndrome (RDS). Secondary outcomes included composite neonatal morbidity (RDS, NEC, IVH grade 3 or 4, sepsis, or death) and mechanical ventilation. Baseline characteristics were compared by ACS exposure, and we tested for interaction between ACS exposure and diabetes status (DM vs no DM). Multivariable logistic regression was used to estimate the association between ACS and neonatal outcomes. RESULTS: 4308 subjects met inclusion criteria: 3664 (85.1%) women received ACS and 644 (14.9%) did not. Of the 500 women who had DM, (179 pre-gestational and 321 GDM), 435 (87.0%) received ACS. Women who received ACS (compared to those who did not) were less likely to be non-Hispanic Black or Hispanic, and more likely to be nulliparous, have higher BMI, chronic hypertension, or preeclampsia (Table 1) . Women who received ACS were more likely to deliver at an earlier gestational age, have maternal or fetal indication for delivery, and deliver a neonate with lower birthweight, and less likely to have labored prior to delivery. There was no significant difference in diabetes status among women who received ACS compared to those who did not. After adjusting for potential confounding factors, ACS was associated with lower odds of composite neonatal morbidity and mechanical ventilation, however, there was no significant association with RDS (Table 2 ). There was no significant effect modification of DM on the relationship between ACS and the neonatal outcomes (p>0.05 for all). CONCLUSION: Maternal DM does not appear to modify the association between ACS exposure and improved neonatal morbidity.
